Education
About Us
Working with TipRanks
Follow Us
Primo Nutraceuticals (BUGVF)
OTHER OTC:BUGVF
Total Valuation
Primo Nutraceuticals has a market cap or net worth of $26.00. The enterprise value is ―.
Market Cap$26.00
Enterprise Value―
Share Statistics
Primo Nutraceuticals has 25,982,025 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,982,025
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Primo Nutraceuticals’s return on equity (ROE) is 7.12 and return on invested capital (ROIC) is -2256.19%.
Return on Equity (ROE)7.12
Return on Assets (ROA)-1.56
Return on Invested Capital (ROIC)-2256.19%
Return on Capital Employed (ROCE)2.19
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Primo Nutraceuticals is -1.74. Primo Nutraceuticals’s PEG ratio is ―.
PE Ratio-1.74
PS Ratio0.00
PB Ratio0.00
Price to Fair Value-12.41
Price to FCF>-0.01
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Primo Nutraceuticals had revenue of 0.00 and earned -3.87M in profits. Earnings per share was -0.88.
Revenue0.00
Gross Profit0.00
Operating Income-1.19M
Pretax Income-3.87M
Net Income-3.87M
EBITDA-1.19M
Earnings Per Share (EPS)-0.88
Cash Flow
In the last 12 months, operating cash flow was -1.41M and capital expenditures 153.69K, giving a free cash flow of -1.26M billion.
Operating Cash Flow-1.41M
Free Cash Flow-1.26M
Free Cash Flow per Share-0.05
Dividends & Yields
Primo Nutraceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change0.00%
50-Day Moving Average0.11
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Primo Nutraceuticals upcoming earnings date is Jul 1, 2020, TBA Not Confirmed.
Last Earnings DateFeb 20, 2020
Next Earnings DateJul 1, 2020
Ex-Dividend Date―
Financial Position
Primo Nutraceuticals as a current ratio of 0.02, with Debt / Equity ratio of -109.71%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.09
Net Debt to EBITDA-0.50
Interest Coverage Ratio-630.32
Taxes
In the past 12 months, Primo Nutraceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate<0.01
Enterprise Valuation
Primo Nutraceuticals EV to EBITDA ratio is -6.17, with an EV/FCF ratio of -5.41.
EV to Sales0.00
EV to EBITDA-6.17
EV to Free Cash Flow-5.41
EV to Operating Cash Flow-6.67
Balance Sheet
Primo Nutraceuticals has $9.95K in cash and marketable securities with C$465.93K in debt, giving a net cash position of $455.98K billion.
Cash & Marketable Securities$9.95K
Total DebtC$465.93K
Net Cash$455.98K
Net Cash Per Share$0.02
Tangible Book Value Per Share-$0.12
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Primo Nutraceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―